European Journal of Dermatology

, Volume 25, Issue 5, pp 488–490 | Cite as

Remission of an epidermodysplasia verruciformis-like eruption in an HIV-positive man long after immune restoration

  • Anne Lise Lecapitaine
  • Véronique Perronne
  • Françoise Granier
Correspondence
  • 18 Downloads

Keywords

Isotretinoin Imiquimod Aseptic Meningitis Cidofovir Etretinate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific HPV. J Invest Dermatol 1984; 83: 18.-25s.CrossRefGoogle Scholar
  2. 2.
    Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 2002; 32: 579–81.PubMedCrossRefGoogle Scholar
  3. 3.
    Rallis E, Paparizos V, Kyriakis K, Katsambas A. Treatment of epidermodysplasia verruciformis in human immunodeficiency virus-positive patients. J Eur Acad Dermatol Venereol 2009; 231:95–6.Google Scholar
  4. 4.
    Kroft EB, Melchers WJ, Blokx WA, de Hoop D, Warris A. A generalized skin eruption in a human immunodeficiency virus-infected boy. J Eur Acad Dermatol Venereol 2008; 2: 896–7.CrossRefGoogle Scholar
  5. 5.
    Carré D, Dompmartin A, Verdon R, et al. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy. Int J Dermatol 2003; 42: 296–300.PubMedCrossRefGoogle Scholar
  6. 6.
    Mermet I, Guerrini JS, Cairey-Remonnay S, et al. Cervical intraepithelial neoplasia associated with epidermodysplasia verruciformis HPV in an HIV-infected patient: a manifestation of immune restoration syndrome. Eur J Dermatol 2007; 17: 149–52.PubMedGoogle Scholar
  7. 7.
    Haas N, Fuchs PG, Hermes B, Henz BM. Remission of epidermodysplasia verruciformis-like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient. Br J Dermatol 2001; 145: 669–70.PubMedCrossRefGoogle Scholar
  8. 8.
    Lee KC, Risser J, Bercovitch L. What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients? Arch Dermatol 2010; 146: 903–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Jacobelli S, Laude H, Carlotti A, et al. Epidermodysplasia verruciformis in human immunodeficiency virus-infected patients: a marker of human papillomavirus-related disorders not affected by antiretroviral therapy. Arch Dermatol 2011; 147: 590–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Darwich E, Darwich L, Ca˜nadas MP, et al. New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir. J Am Acad Dermatol 2011; 65: e43–5.PubMedCrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2015

Authors and Affiliations

  • Anne Lise Lecapitaine
    • 1
  • Véronique Perronne
    • 1
  • Françoise Granier
    • 1
  1. 1.Department of Internal medicine and Infectious DiseasesFrançois Quesnay General HospitalMantes-la-JolieFrance

Personalised recommendations